118 related articles for article (PubMed ID: 21642838)
1. Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
Xiao XY; Jiang GS; Wang L; Lv L; Zeng FQ
Anticancer Drugs; 2011 Oct; 22(9):853-63. PubMed ID: 21642838
[TBL] [Abstract][Full Text] [Related]
2. AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
Jiang G; Zhao J; Xiao X; Tao D; Gu C; Tong Q; Luo B; Wang L; Zeng F
Cancer Lett; 2011 Mar; 302(1):37-46. PubMed ID: 21237556
[TBL] [Abstract][Full Text] [Related]
3. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
[TBL] [Abstract][Full Text] [Related]
4. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
[TBL] [Abstract][Full Text] [Related]
5. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
[TBL] [Abstract][Full Text] [Related]
6. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
7. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.
Milrot E; Jackman A; Kniazhanski T; Gonen P; Flescher E; Sherman L
Cancer Lett; 2012 Jun; 319(1):31-8. PubMed ID: 22198483
[TBL] [Abstract][Full Text] [Related]
8. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
Raviv Z; Zilberberg A; Cohen S; Reischer-Pelech D; Horrix C; Berger MR; Rosin-Arbesfeld R; Flescher E
Br J Pharmacol; 2011 Nov; 164(5):1433-44. PubMed ID: 21486277
[TBL] [Abstract][Full Text] [Related]
9. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells.
Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH
Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975
[TBL] [Abstract][Full Text] [Related]
10. Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family.
Mahdavi M; Davoodi J; Zali MR; Foroumadi A
Biomed Pharmacother; 2011 Jun; 65(3):175-82. PubMed ID: 21565459
[TBL] [Abstract][Full Text] [Related]
11. Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines.
Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH
Anticancer Drugs; 2008 Jul; 19(6):573-81. PubMed ID: 18525316
[TBL] [Abstract][Full Text] [Related]
12. [Methyl jasmonate induces apoptosis of human neuroblastoma cell line BE(2) -C and its mechanism].
Jiang GS; Tong QS; Zeng FQ; Hu B; Zheng LD; Cai JB; Liu Y
Yao Xue Xue Bao; 2008 Jun; 43(6):584-90. PubMed ID: 18822959
[TBL] [Abstract][Full Text] [Related]
13. ANTP-SmacN7 fusion peptide-induced radiosensitization in A549 cells and its potential mechanisms.
Zhang R; Sun H; Wang H; Zhang W; Geng K; Liu Q; Wang P
Thorac Cancer; 2020 May; 11(5):1271-1279. PubMed ID: 32155687
[TBL] [Abstract][Full Text] [Related]
14. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
[TBL] [Abstract][Full Text] [Related]
15. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
Yeruva L; Pierre KJ; Bathina M; Elegbede A; Carper SW
Cancer Invest; 2008 Nov; 26(9):890-9. PubMed ID: 18798057
[TBL] [Abstract][Full Text] [Related]
16. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
17. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
Yeruva L; Hall C; Elegbede JA; Carper SW
Anticancer Drugs; 2010 Jan; 21(1):1-9. PubMed ID: 19820395
[TBL] [Abstract][Full Text] [Related]
18. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
19. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
Cohen S; Flescher E
Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of IAP proteins: novel anti-tumor agents.
Wan Y; Liu T; Hou X; Dun Y; Guan P; Fang H
Curr Med Chem; 2014; 21(34):3877-92. PubMed ID: 25174926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
